![N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide](https://static.cymitquimica.com/products/3D/img/EQB75796.png "Haga clic para ampliar")
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide
CAS: 1004757-96-3
Ref. 3D-EQB75796
| 100mg | A consultar | |
| 250mg | A consultar |
Información del producto
N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide (NAPQI) is a new drug that is being developed for the treatment of autoimmune and inflammatory diseases. It inhibits tumor necrosis factor alpha (TNFα), which is a cytokine involved in the immune response, leading to decreased inflammation. NAPQI also has the ability to inhibit the production of macrophage chemotactic protein 1 (MCP1), which is a chemokine involved in the inflammatory process. NAPQI can be used as a prodrug and modulates receptor activity by binding to TNFα, leading to reduced inflammation.
Propiedades químicas
Consulta técnica sobre: 3D-EQB75796 N-[5-[Methyl(propan-2-yl)amino]-2-[2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
